The sources told Daily News Egypt that negotiations regarding the acquisition are still ongoing, with potential aggregate deal values exceeding EGP 1.5bn, supporting the platform’s strategy of expanding its investments in the pharmaceuticals sector and capitalising on the track record achieved in U Pharma.

The platform is currently at advanced stages of negotiation and execution with potential aggregate deal values exceeding EGP 1bn, supporting EFG Hermes’s strategy of expanding its investments in the pharmaceuticals sector.